US: CHMMF - Chimeric Therapeutics Limited

Lønnsomhet i seks måneder: 0%
Utbytte: 0.00%

Kampanjeplan Chimeric Therapeutics Limited

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Chimeric Therapeutics Limited

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma.

flere detaljer
It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.chimerictherapeutics.com
Цена ао 0.001
Prisendring per dag: 0% (0.001)
Prisendring per uke: 0% (0.001)
Prisendring per måned: 0% (0.001)
Prisendring over 3 måneder: 0% (0.001)
Prisendring over seks måneder: 0% (0.001)
Prisendring per år: -96.67% (0.03)
Prisendring siden begynnelsen av året: 0% (0.001)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 12.71 1
P/E 0 0
EV/EBITDA -1.54 0
Total: 2.63

Effektivitet

Navn Betydning Karakter
ROA, % -66.56 0
ROE, % -308.21 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.1719 10
Total: 8.2

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 105720.11 10
Lønnsomhet Ebitda, % 19896.88 10
Lønnsomhet EPS, % 6411.63 10
Total: 10
Flere detaljer

Veileder Stillingstittel Betaling Fødselsår
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD Founder & Executive Chairman 1956 (69 år)
Mr. Jason B. Litten M.D. Chief Medical Officer 1974 (51 år)
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A. CFO, Joint Company Secretary & Director 1959 (66 år)
Dr. Rebecca McQualter Chief Operating Officer
Mr. Kelly R. Thornburg VP & Head of Quality 1963 (62 år)
Mr. Nathan Jong C.A. Company Secretary

Adresse: Australia, Carlton, 62 Lygon Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.chimerictherapeutics.com